期刊簡介 | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | STATISTICAL METHODS IN MEDICAL RESEARCH LetPub Score 5.3
50 ratings
Rate
Reputation 6.3 Influence 4.0 Speed 7.0 | ||||||||||||||||||||||||||
期刊簡稱 | STAT METHODS MED RES | ||||||||||||||||||||||||||
ISSN | 0962-2802 | ||||||||||||||||||||||||||
E-ISSN | 1477-0334 | ||||||||||||||||||||||||||
h-index | 71 | ||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||
自引率 (2023-2024) | 6.20%自引率趨勢 | ||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||
官方網站 | http://smm.sagepub.com/ | ||||||||||||||||||||||||||
在線稿件提交 | https://us.sagepub.com/en-us/nam/journal/statistical-methods-medical-research#submission-guidelines | ||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||
出版商 | SAGE Publications Ltd | ||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||
創刊年 | 1992 | ||||||||||||||||||||||||||
每年文章數 | 129每年文章數趨勢 | ||||||||||||||||||||||||||
黃金OA百分比 | 23.88% | ||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0962-2802%5BISSN%5D | ||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[STATISTICAL METHODS IN MEDICAL RESEARCH] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:55:47 評論於 When responding to reviewers' comments, all questions must be addressed point by point without omission. Try to meet the experimental requirements suggested in the comments, and if unable to do so, provide reasonable reasons for not being able to. The literature recommended by the reviewers must be cited and discussed thoroughly. Before resubmitting the revised manuscript, make sure to double-check the corrections made in the original draft. If agreeing with the modifications suggested by the editor, simply accept the changes. If disagreeing, write down your reasons below the annotations and provide feedback to the editor. In case of conflicting opinions, negotiate further(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:54:17 評論於 If conditions allow, try to supplement the experiment as much as possible. If it is really impossible, then seriously consider the reasons for defense, but a humble and cautious attitude is essential. After all, there is a certain rejection rate for major revisions(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 09:36:30 評論於 The reviewers requested that I supplement the experiment, but my samples have been used up/experiment has ended. Will my paper be rejected if I directly say that my samples have been used up?(0) 讚! | 平原文波 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 08:12:23 評論於 What is the difference between responding to reviewer comments and responding to editor comments?(0) 讚! | 北国博达 |
作者: phadnismilind@gmail.com 領域: 数理科学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2019-02-21 16:18:02 評論於 Exact time taken for the first review was 2.5 months. The review was reasonable and it took me 2 weeks to complete the revisions. The second review took another 1 month after which the paper was accepted. (1) 讚! | phadnismilind@gmail.com |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-30 21:30:45 評論於 Overall, the situation looks quite positive. It's close to 3 points this year, which is much higher than last year. It should reach 3 points next year(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us